SR One For Profit
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.
Invests into
%20.jpg)
.jpg)
Acquisitions Number:
NA
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
N/A
Zip:
NA
Employee Number:
1-10
Estimated Revenue:
$8.1 Million
Investment Stage:
Series A, Series C
Number Of Exists:
53
Investor Type:
Corporate Venture Capital
Investors Number:
NA
Founded Date:
1985-01-01
Industry:
Finance & Banking